High-risk neuroblastoma is currently incurable, and we urgently need a new approach. Immunotherapy is showing promise as a way to kill cancer cells, so we’re funding this project to help find a way to enable children’s own immune systems to fight back.
Dr David and his team are working on a way to modify cells in the body’s own immune system so they can target and kill cancer cells – a possible cure for an incurable childhood cancer.
Enhancing immunity against neuroblastoma through the exploitation of antigen-specific T cell co-stimulation receptors
Dr David Gilham
University of Manchester
Manchester, M20 4BX
5 November 2013